Tandem Diabetes Care, Inc.
TNDM Real Time Price USDRecent trades of TNDM by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in TNDM holdings by institutional investors
Quarterly net insider trading by TNDM's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$50,000 Oct 09, 2025 Issue: Medicare/Medicaid Budget/Appropriations
-
$50,000 Jul 17, 2025 Issue: Medicare/Medicaid Budget/Appropriations
-
$50,000 Apr 17, 2025 Issue: Medicare/Medicaid Budget/Appropriations
-
$20,000 Jan 21, 2025 Issue: None
TNDM Estimated quarterly lobbying spending
TNDM Revenue by Segment or Geography
New TNDM patent grants
-
Patent Title: Display screen or portion thereof with graphical user interface Feb. 13, 2024
-
Patent Title: User-wearable holder for medical device Jan. 09, 2024
-
Patent Title: Display screen or portion thereof with graphical user interface Mar. 07, 2023
-
Patent Title: Medical device display screen or portion thereof with graphical user interface Dec. 14, 2021
-
Patent Title: Display screen or portion thereof with graphical user interface Sep. 21, 2021
-
Patent Title: Display screen or portion thereof with graphical user interface May. 04, 2021
-
Patent Title: Display screen or portion thereof with graphical user interface Apr. 07, 2020
-
Patent Title: Display screen or portion thereof with graphical user interface Feb. 18, 2020
-
Patent Title: Display screen or portion thereof with graphical user interface Feb. 18, 2020
-
Patent Title: Display screen or portion thereof with graphical user interface Feb. 18, 2020
-
Patent Title: Display screen or portion thereof with graphical user interface Oct. 22, 2019
-
Patent Title: Display screen or portion thereof with graphical user interface Oct. 22, 2019
-
Patent Title: Display screen or portion thereof with graphical user interface Oct. 22, 2019
-
Patent Title: Patch pump cartridge attachment Jun. 12, 2018
-
Patent Title: System and method for detecting occlusions in an infusion pump May. 08, 2018
-
Patent Title: System and method for maximum insulin pump bolus override Apr. 10, 2018
-
Patent Title: Infusion pump with temperature monitoring Feb. 13, 2018
-
Patent Title: System and method for infusion set dislodgement detection Jan. 16, 2018
-
Patent Title: System and method for mitigating risk in automated medicament dosing Jan. 16, 2018
-
Patent Title: Insulin pump based expert system Dec. 05, 2017
-
Patent Title: Device and method for training users of ambulatory medical devices Nov. 14, 2017
-
Patent Title: Sealed infusion device with electrical connector port Sep. 05, 2017
-
Patent Title: Pump device with multiple medicament reservoirs Sep. 05, 2017
-
Patent Title: Integration of infusion pump with remote electronic device Aug. 22, 2017
-
Patent Title: Preventing inadvertent changes in ambulatory medical devices Jul. 25, 2017
-
Patent Title: Temporary suspension for closed-loop medicament therapy Jun. 06, 2017
-
Patent Title: Device and method for setting therapeutic parameters for an infusion device Mar. 28, 2017
-
Patent Title: System and method for detecting and transmitting medical device alarm with a smartphone application Feb. 07, 2017
-
Patent Title: Infusion pump system with disposable cartridge having pressure venting and pressure feedback Jan. 31, 2017
-
Patent Title: Therapy management system Nov. 22, 2016
-
Patent Title: Method and device utilizing insulin delivery protocols Nov. 15, 2016
-
Patent Title: Safety processor for wireless control of a drug delivery device Nov. 08, 2016
-
Patent Title: Predictive calibration Nov. 08, 2016
-
Patent Title: Expert system for infusion pump therapy Oct. 25, 2016
-
Patent Title: Infusion device occlusion detection system Aug. 23, 2016
-
Patent Title: Solute concentration measurement device and related methods Jul. 26, 2016
-
Patent Title: Sealed infusion device with electrical connector port Jul. 05, 2016
-
Patent Title: System and method for reduction of inadvertent activation of medical device during manipulation May. 10, 2016
-
Patent Title: Methods and devices for determination of flow reservoir volume Feb. 02, 2016
-
Patent Title: Field update of an ambulatory infusion pump system Jan. 26, 2016
-
Patent Title: Device and method for training users of ambulatory medical devices Jan. 19, 2016
-
Patent Title: Infusion pump system with disposable cartridge having pressure venting and pressure feedback Dec. 15, 2015
-
Patent Title: Detection of infusion pump conditions Nov. 10, 2015
-
Patent Title: Methods and devices for multiple fluid transfer Nov. 10, 2015
-
Patent Title: System and method for detecting occlusions in an infusion pump Nov. 03, 2015
-
Patent Title: Systems and methods to address air, leaks and occlusions in an insulin pump system Sep. 01, 2015
-
Patent Title: Expert system for insulin pump therapy Apr. 14, 2015
-
Patent Title: Insulin pump having correction factors Apr. 07, 2015
-
Patent Title: Two chamber pumps and related methods Mar. 24, 2015
-
Patent Title: Infusion pump system with disposable cartridge having pressure venting and pressure feedback Jan. 06, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded to TNDM from public contracts
Recent insights relating to TNDM
Recent picks made for TNDM stock on CNBC
ETFs with the largest estimated holdings in TNDM
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $TNDM stock a Buy, Sell, or Hold?
- What is the price target for $TNDM stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $TNDM stock?
- Who owns the most shares of $TNDM stock?
- What funds own $TNDM stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TNDM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
- Address San Diego, CA
- Market Cap 1.4 billion
- Employees 2,650
- Industrial Classification Surgical & Medical Instruments & Apparatus